A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010

NCT05867121 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer
Gastric Cancer
Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: RO7496353
DRUG: Atezolizumab
DRUG: Capecitabine
DRUG: S-1
DRUG: Nivolumab
DRUG: Oxaliplatin
DRUG: Nab-paclitaxel
DRUG: Gemcitabine

Sponsor

Genentech, Inc.

Collaborators

[object Object]